How good are US dermatologists at discriminating skin cancers? A number-needed-to-treat analysis

Journal of Dermatological Treatment

Volumn 23, Issue 1, 2012, Pages 65-69

  Wilson, Rebekah L ^a   Yentzer, Brad A ^a   Isom, Scott P ^a   Feldman, Steven R ^a   Fleischer, Alan B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Malignancy ratio; Quality

Indexed keywords

AGE; ARTICLE; CANCER DIAGNOSIS; CLINICAL COMPETENCE; DERMATOLOGIST; GENDER; HUMAN; MELANOMA; NUMBERS NEEDED TO TREAT; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER;

EID: 84863394155     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2010.512951     Document Type: Article

References (5)

1. Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Goldman ND, Acostamadiedo JM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48(3):425-429. (Pubitemid 36337080)
2. Chen JG, Fleischer AB Jr, Smith ED, Kancler C, Goldman ND, Williford PM, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035-1038. (Pubitemid 34019722)
3. Hansen C, Wilkinson D, Hansen M, Argenziano G. How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia. J Am Acad Dermatol. 2009;61(4):599-604.
4. Green AR, Elgart GW, Ma F, Federman DG, Kirsner RS. Documenting dermatology practice: Ratio of cutaneous tumors biopsied that are malignant. Dermatol Surg. 2004;30(9): 1208-1209. (Pubitemid 39312243)
5. Soares TF, Laman SD, Yiannias JA, Connolly SM, Lim KK, Wu Q, et al. Factors leading to the biopsy of 1547 pigmented lesions at Mayo Clinic, Scottsdale, Arizona, in 2005. Int J Dermatol. 2009;48(10):1053-1056.